Cat Allergy Vaccine Development Under Way
Media reports have suggested that an asthma vaccine is imminent. Initial research has focused on a vaccine for people with a cat allergy. Experts, however, have stated that, although the results are encouraging, a real vaccine is still years away.
Prof. Barry Kay, MD, PhD, and Dr. Mark Larch?, PhD, at the National Heart and Lung Institute, Imperial College, London, have developed a prototype vaccine for people with an allergy to cats. This prototype could eventually be applied to many allergens, including pollen and dust mites. Using the structure of whole allergens, they have designed a synthetic vaccine. This approach is unlike allergy shots, because it targets only the body?s T cells, which direct the allergic response. Instead of injecting the whole allergen, the researchers use only the small parts of it that react with T cells. This approach reduces the risk of side effects and allows a higher dose of treatment to be administered, compared with conventional immunotherapy.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025